{{PBB|geneid=1356}}
'''Ceruloplasmin''' (or '''caeruloplasmin''') is a [[ferroxidase]] [[enzyme]] that in humans is encoded by the ''CP'' [[gene]].<ref name="pmid6582496">{{cite journal | author = Takahashi N, Ortel TL, Putnam FW | title = Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 81 | issue = 2 | pages = 390–4 | year = 1984 | month = January | pmid = 6582496 | pmc = 344682 | doi = 10.1073/pnas.81.2.390 | url = | issn = }}</ref><ref name="pmid2873574">{{cite journal | author = Koschinsky ML, Funk WD, van Oost BA, MacGillivray RT | title = Complete cDNA sequence of human preceruloplasmin | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 83 | issue = 14 | pages = 5086–90 | year = 1986 | month = July | pmid = 2873574 | pmc = 323895 | doi = 10.1073/pnas.83.14.5086 | url = | issn = }}</ref><ref name="pmid3474786">{{cite journal | author = Royle NJ, Irwin DM, Koschinsky ML, MacGillivray RT, Hamerton JL | title = Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively | journal = Somat. Cell Mol. Genet. | volume = 13 | issue = 3 | pages = 285–92 | year = 1987 | month = May | pmid = 3474786 | doi = 10.1007/BF01535211 | url = | issn = }}</ref>

Ceruloplasmin is the major [[copper]]-carrying protein in the blood, and in addition plays a role in [[iron metabolism]]. It was first described in 1948.<ref>{{cite journal | author=Holmberg CG, Laurell C-B | title=Investigations in serum copper. II. Isolation of the Copper containing protein, and a description of its properties | journal=Acta Chem Scand | year=1948 | volume=2 | pages=550–56 | doi=10.3891/acta.chem.scand.02-0550}}</ref> Another protein, [[hephaestin]], is noted for its homology to ceruloplasmin, and also participates in iron and probably copper metabolism.

==Function==
It is an [[enzyme]] ({{EC  number|1.16.3.1}}) synthesized in the liver containing 8 atoms of [[copper]] in its structure. Ceruloplasmin carries about 70% of the total copper in human plasma while albumin carries about 15%. The rest is accounted for by macroglobulins. Albumin may be confused at times to have a greater importance as a copper carrier because it binds copper less tightly than ceruloplasmin. Ceruloplasmin exhibits a copper-dependent oxidase activity, which is associated with possible oxidation of Fe<sup>2+</sup> (ferrous iron) into Fe<sup>3+</sup> (ferric iron), therefore assisting in its transport in the plasma in association with [[transferrin]], which can carry iron only in the ferric state.  The molecular weight of human ceruloplasmin is reported to be 151kDa.

==Pathology==
Like any other plasma protein, levels drop in patients with hepatic disease due to reduced synthesizing capabilities. 

Mechanisms of low ceruplasmin levels: 
* Gene expression genetically low ([[aceruloplasminemia]])
* Copper levels are low in general
** [[Malnutrition]]/trace metal deficiency in the food source
* Copper does not cross the intestinal barrier due to [[ATP7A]] deficiency ([[Menkes disease]])
* Delivery of copper into the lumen of the [[Endoplasmic reticulum|ER]]-[[Golgi apparatus|Golgi]] network is absent in [[hepatocyte]]s due to absent [[ATP7B]] ([[Wilson's disease]])

Copper availability doesn't affect the translation of the nascent protein. However, the apoenzyme without copper is unstable. Apoceruloplasmin is largely degraded intracellularly in the [[hepatocyte]] and the small amount that is released has a short circulation half life of 5 hours as compared to the 5.5 days for the holo-ceruloplasmin.  

Mutations in the ceruloplasmin gene (''CP''), which are very rare, can lead to the genetic disease [[aceruloplasminemia]], characterized by hyperferritinemia with iron overload. In the brain, this iron overload may lead to characteristic neurologic signs and symptoms, such as cerebellar [[ataxia]], progressive [[dementia]], and [[extrapyramidal signs]]. Excess iron may also deposit in the liver, pancreas, and retina, leading to [[cirrhosis]], [[endocrine]] abnormalities, and loss of vision, respectively.

==Interpretation==

===Decreased levels===
Lower-than-normal ceruloplasmin levels may indicate the following:
* [[Wilson disease]] (a rare (UK incidence 1/100,000) copper storage disease)<ref>{{cite journal | author=Scheinberg IH, Gitlin D | title=Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson disease) | journal=Science | year=1952 | month=October | volume=116 | issue=3018 | pages=484–5 | pmid=12994898 | doi=10.1126/science.116.3018.484}}</ref>
* [[Menkes disease]] (Menke kinky hair syndrome) (rare - UK incidence 1/100,000)
* Overdose of [[Vitamin C]]
* [[Copper]] deficiency
* [[Aceruloplasminemia]]<ref>{{cite journal  | author=Gitlin JD |title=Aceruloplasminemia |journal=Pediatr. Res. |volume=44 |issue= 3 |pages= 271–6 |year= 1998 |pmid= 9727700 |doi=  10.1203/00006450-199809000-00001}}</ref>

===Elevated levels===
Greater-than-normal ceruloplasmin levels may indicate or be noticed in:
* [[pregnancy]]
* [[oral contraceptive pill]] use <ref>http://journals.lww.com/anesthesiology/Fulltext/2008/04000/Green_Plasma_Revisited.35.aspx</ref>
* [[lymphoma]]
* acute and chronic [[inflammation]] (it is an [[acute-phase reaction|acute-phase reactant]])
* [[rheumatoid arthritis]]
* [[Angina pectoris|Angina]] <ref>http://ang.sagepub.com/cgi/content/abstract/60/1/50?rss=1</ref>
* [[Alzheimer's disease]]<ref name="pmid18534184">{{cite journal | author = Lutsenko S, Gupta A, Burkhead JL, Zuzel V | title = Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance | journal = Arch. Biochem. Biophys. | volume = 476 | issue = 1 | pages = 22–32 | year = 2008 | month = August | pmid = 18534184 | doi = 10.1016/j.abb.2008.05.005 | url = | issn = | pmc = 2556376 }}</ref>
* [[Schizophrenia]]<ref name="pmid16842975">{{cite journal | author = Wolf TL, Kotun J, Meador-Woodruff JH | title = Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia | journal = Schizophr. Res. | volume = 86 | issue = 1–3 | pages = 167–71 | year = 2006 | month = September | pmid = 16842975 | doi = 10.1016/j.schres.2006.05.027 | url = }}</ref>
* [[Obsessive-compulsive disorder]]<ref name="pmid19017404">{{cite journal | author = Virit O, Selek S, Bulut M, Savas HA, Celik H, Erel O, Herken H | title = High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study | journal = Behav Brain Funct | volume = 4 | issue = | pages = 52 | year = 2008 | pmid = 19017404 | pmc = 2596773 | doi = 10.1186/1744-9081-4-52 | url = }}</ref>

===Reference ranges===
[[File:Blood values sorted by mass and molar concentration.png|thumb|left|450px|[[Reference ranges for blood tests]], comparing blood content of ceruloplasmin (shown in gray) with other constituents.]]
{{-}}

==Regulation==

A [[cis-regulatory element]] called the [[GAIT element]] is involved in the selective translational silencing of the Ceruloplasmin transcript.<ref>{{cite journal | last = Sampath | first = P | coauthors = Mazumder B, Seshadri V, Fox PL | year = 2003 | title = Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3' untranslated region | journal = Mol Cell Biol | volume = 23 | issue = 5 | pages = 1509&ndash;1519 | pmid = 12588972 | pmc = 151701 | doi = 10.1128/MCB.23.5.1509-1519.2003}}</ref>
The silencing requires binding of a cytosolic inhibitor complex called IFN-gamma-activated inhibitor of translation (GAIT) to the GAIT element.<ref name="pmid16267389">{{cite journal |author=Mazumder B, Sampath P, Fox PL |title=Regulation of macrophage ceruloplasmin gene expression: one paradigm of 3'-UTR-mediated translational control |journal=Mol Cells |volume=20 |issue=2 |pages=167–72 |year=2005 |pmid=16267389}}</ref>

==References==
{{reflist}}

==Further reading==
{{refbegin | 2}}
*{{cite journal  | author=Hellman NE, Gitlin JD |title=Ceruloplasmin metabolism and function |journal=Annu. Rev. Nutr. |volume=22 |issue=  |pages= 439–58 |year= 2002 |pmid= 12055353 |doi= 10.1146/annurev.nutr.22.012502.114457 }}
*{{cite journal  | author=Mazumder B, Seshadri V, Fox PL |title=Translational control by the 3'-UTR: the ends specify the means |journal=Trends Biochem. Sci. |volume=28 |issue= 2 |pages= 91–8 |year= 2003 |pmid= 12575997 |doi=  10.1016/S0968-0004(03)00002-1}}
*{{cite journal  | author=Giurgea N, Constantinescu MI, Stanciu R, ''et al.'' |title=Ceruloplasmin - acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease |journal=Med. Sci. Monit. |volume=11 |issue= 2 |pages= RA48–51 |year= 2005 |pmid= 15668644 |doi=  }}
*{{cite journal  | author=Kingston IB, Kingston BL, Putnam FW |title=Chemical evidence that proteolytic cleavage causes the heterogeneity present in human ceruloplasmin preparations |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=74 |issue= 12 |pages= 5377–81 |year= 1978 |pmid= 146197 |doi=10.1073/pnas.74.12.5377  | pmc=431726  }}
*{{cite journal  | author=Polosatov MV, Klimov PK, Masevich CG, ''et al.'' |title=Interaction of synthetic human big gastrin with blood proteins of man and animals |journal=Acta hepato-gastroenterologica |volume=26 |issue= 2 |pages= 154–9 |year= 1979 |pmid= 463490 |doi=  }}
*{{cite journal  | author=Schilsky ML, Stockert RJ, Pollard JW |title=Caeruloplasmin biosynthesis by the human uterus |journal=Biochem. J. |volume=288 |issue=  2|pages= 657–61 |year= 1993 |pmid= 1463466 |doi=  | pmc=1132061  }}
*{{cite journal  | author=Walker FJ, Fay PJ |title=Characterization of an interaction between protein C and ceruloplasmin |journal=J. Biol. Chem. |volume=265 |issue= 4 |pages= 1834–6 |year= 1990 |pmid= 2105310 |doi=  }}
*{{cite journal  | author=Fleming RE, Gitlin JD |title=Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development |journal=J. Biol. Chem. |volume=265 |issue= 13 |pages= 7701–7 |year= 1990 |pmid= 2332446 |doi=  }}
*{{cite journal  | author=Yang FM, Friedrichs WE, Cupples RL, ''et al.'' |title=Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing |journal=J. Biol. Chem. |volume=265 |issue= 18 |pages= 10780–5 |year= 1990 |pmid= 2355023 |doi=  }}
*{{cite journal  | author=Yang F, Naylor SL, Lum JB, ''et al.'' |title=Characterization, mapping, and expression of the human ceruloplasmin gene |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=83 |issue= 10 |pages= 3257–61 |year= 1986 |pmid= 3486416 |doi=  10.1073/pnas.83.10.3257  | pmc=323492}}
*{{cite journal  | author=Mercer JF, Grimes A |title=Isolation of a human ceruloplasmin cDNA clone that includes the N-terminal leader sequence |journal=FEBS Lett. |volume=203 |issue= 2 |pages= 185–90 |year= 1986 |pmid= 3755405 |doi=  10.1016/0014-5793(86)80739-6}}
*{{cite journal  | author=Rask L, Valtersson C, Anundi H, ''et al.'' |title=Subcellular localization in normal and vitamin A-deficient rat liver of vitamin A serum transport proteins, albumin, ceruloplasmin and class I major histocompatibility antigens |journal=Exp. Cell Res. |volume=143 |issue= 1 |pages= 91–102 |year= 1983 |pmid= 6337857 |doi=  10.1016/0014-4827(83)90112-X}}
*{{cite journal  | author=Kressner MS, Stockert RJ, Morell AG, Sternlieb I |title=Origins of biliary copper |journal=Hepatology |volume=4 |issue= 5 |pages= 867–70 |year= 1984 |pmid= 6479854 |doi=10.1002/hep.1840040512  }}
*{{cite journal  | author=Takahashi N, Bauman RA, Ortel TL, ''et al.'' |title=Internal triplication in the structure of human ceruloplasmin |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=80 |issue= 1 |pages= 115–9 |year= 1983 |pmid= 6571985 |doi=  10.1073/pnas.80.1.115  | pmc=393320}}
*{{cite journal  | author=Dwulet FE, Putnam FW |title=Complete amino acid sequence of a 50,000-dalton fragment of human ceruloplasmin |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=78 |issue= 2 |pages= 790–4 |year= 1981 |pmid= 6940148 |doi=  10.1073/pnas.78.2.790  | pmc=319888}}
*{{cite journal  | author=Kingston IB, Kingston BL, Putnam FW |title=Primary structure of a histidine-rich proteolytic fragment of human ceruloplasmin. I. Amino acid sequence of the cyanogen bromide peptides |journal=J. Biol. Chem. |volume=255 |issue= 7 |pages= 2878–85 |year= 1980 |pmid= 6987229 |doi=  }}
{{refend}}

==External links==
* [http://www.ncbi.nlm.nih.gov/books/NBK1493/  GeneReviews/NCBI/NIH/UW entry on Aceruloplasminemia]
* [http://www.ncbi.nlm.nih.gov/omim/117700,604290,117700,604290  OMIM entries on Aceruloplasminemia]

{{PDB Gallery|geneid=1356}}
{{Other oxidoreductases}}
{{Carrier proteins}}
{{Alpha globulins}}
{{Acute phase proteins}} 
{{Iron metabolism}}

[[Category:Acute phase proteins]]
[[Category:Chemical pathology]]
[[Category:EC 1.16.3]]
[[Category:Hepatology]]
[[Category:Iron metabolism]]